The Federal Commission for the Protection against Sanitary Risks (Cofepris), anticipated that by 2018 Mexican pharmacies would already have marijuana-based drugs available, which will mean savings for those patients who require them.
In a press conference in the framework of the International Week of Science and Good Regulatory Practices, the head of Cofepris, Julio Sánchez y Tépoz, pointed out that this is the most important part of the reform to the General Health Law, whose is currently being prepared and will be ready on 20 December.
“The decree that reforms our General Health Law and eliminates the absolute prohibition on cannabis, will allow, based on the rules we have to issue by December, that there are products available to the public in pharmacies, with cannabis content, to therapeutic use” he said.
Individual permits are currently granted for this consumption and the interested parties have to absorb, in addition to the cost of the medicine, the import costs. Once the relevant regulation is in place and the reform enters into force, the supply of this type of products will be available in national establishments.